Cargando…
Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis
Solute carrier family 7 member 2 (SLC7A2, also known as CAT2) is an inducible transporter of the semi-essential amino acid L-arginine (L-Arg), which has been implicated in wound repair. We have reported that both SLC7A2 expression and L-Arg availability are decreased in colonic tissues from inflamma...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377304/ https://www.ncbi.nlm.nih.gov/pubmed/30202097 http://dx.doi.org/10.1038/s41388-018-0492-9 |
_version_ | 1783395718222839808 |
---|---|
author | Coburn, Lori A. Singh, Kshipra Asim, Mohammad Barry, Daniel P. Allaman, Margaret M. Al-Greene, Nicole T. Hardbower, Dana M. Polosukhina, Dina Williams, Christopher S. Delgado, Alberto G. Piazuelo, M. Blanca Washington, M. Kay Gobert, Alain P. Wilson, Keith T. |
author_facet | Coburn, Lori A. Singh, Kshipra Asim, Mohammad Barry, Daniel P. Allaman, Margaret M. Al-Greene, Nicole T. Hardbower, Dana M. Polosukhina, Dina Williams, Christopher S. Delgado, Alberto G. Piazuelo, M. Blanca Washington, M. Kay Gobert, Alain P. Wilson, Keith T. |
author_sort | Coburn, Lori A. |
collection | PubMed |
description | Solute carrier family 7 member 2 (SLC7A2, also known as CAT2) is an inducible transporter of the semi-essential amino acid L-arginine (L-Arg), which has been implicated in wound repair. We have reported that both SLC7A2 expression and L-Arg availability are decreased in colonic tissues from inflammatory bowel disease patients and that mice lacking Slc7a2 exhibit a more severe disease course when exposed to dextran sulfate sodium (DSS) compared to wild-type (WT) mice. Here, we present evidence that SLC7A2 plays a role in modulating colon tumorigenesis in the azoxymethane(AOM)-DSS model of colitis-associated carcinogenesis (CAC). SLC7A2 was localized predominantly to colonic epithelial cells in WT mice. Utilizing the AOM-DSS model, Slc7a2(–/–) mice had significantly increased tumor number, burden, and risk of high-grade dysplasia versus WT mice. Tumors from Slc7a2(–/–) mice exhibited significantly increased levels of the proinflammatory cytokines/chemokines IL-1β, CXCL1, CXCL5, IL-3, CXCL2, CCL3, and CCL4, but decreased levels of IL-4, CXCL9, and CXCL10 compared to tumors from WT mice. This was accompanied by a shift toward pro-tumorigenic M2 macrophage activation in Slc7a2-deficient mice, as marked by increased colonic CD11b(+)F4/80(+)ARG1(+) cells with no alteration in CD11b(+)F4/80(+)NOS2(+) cells by flow cytometry and immunofluorescence microscopy. The shift toward M2 macrophage activation was confirmed in bone marrow-derived macrophages from Slc7a2(–/–) mice. In bone marrow chimeras between Slc7a2(–/–) and WT mice, the recipient genotype drove the CAC phenotype, suggesting the importance of epithelial SLC7A2 in abrogating neoplastic risk. These data reveal that SLC7A2 has a significant role in the protection from CAC in the setting of chronic colitis, and suggest that the decreased SLC7A2 in inflammatory bowel disease (IBD) may contribute to CAC risk. Strategies to enhance L-Arg availability by supplementing L-Arg and/or increasing L-Arg uptake could represent a therapeutic approach in IBD to reduce the substantial long-term risk of colorectal carcinoma. |
format | Online Article Text |
id | pubmed-6377304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-63773042019-03-10 Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis Coburn, Lori A. Singh, Kshipra Asim, Mohammad Barry, Daniel P. Allaman, Margaret M. Al-Greene, Nicole T. Hardbower, Dana M. Polosukhina, Dina Williams, Christopher S. Delgado, Alberto G. Piazuelo, M. Blanca Washington, M. Kay Gobert, Alain P. Wilson, Keith T. Oncogene Article Solute carrier family 7 member 2 (SLC7A2, also known as CAT2) is an inducible transporter of the semi-essential amino acid L-arginine (L-Arg), which has been implicated in wound repair. We have reported that both SLC7A2 expression and L-Arg availability are decreased in colonic tissues from inflammatory bowel disease patients and that mice lacking Slc7a2 exhibit a more severe disease course when exposed to dextran sulfate sodium (DSS) compared to wild-type (WT) mice. Here, we present evidence that SLC7A2 plays a role in modulating colon tumorigenesis in the azoxymethane(AOM)-DSS model of colitis-associated carcinogenesis (CAC). SLC7A2 was localized predominantly to colonic epithelial cells in WT mice. Utilizing the AOM-DSS model, Slc7a2(–/–) mice had significantly increased tumor number, burden, and risk of high-grade dysplasia versus WT mice. Tumors from Slc7a2(–/–) mice exhibited significantly increased levels of the proinflammatory cytokines/chemokines IL-1β, CXCL1, CXCL5, IL-3, CXCL2, CCL3, and CCL4, but decreased levels of IL-4, CXCL9, and CXCL10 compared to tumors from WT mice. This was accompanied by a shift toward pro-tumorigenic M2 macrophage activation in Slc7a2-deficient mice, as marked by increased colonic CD11b(+)F4/80(+)ARG1(+) cells with no alteration in CD11b(+)F4/80(+)NOS2(+) cells by flow cytometry and immunofluorescence microscopy. The shift toward M2 macrophage activation was confirmed in bone marrow-derived macrophages from Slc7a2(–/–) mice. In bone marrow chimeras between Slc7a2(–/–) and WT mice, the recipient genotype drove the CAC phenotype, suggesting the importance of epithelial SLC7A2 in abrogating neoplastic risk. These data reveal that SLC7A2 has a significant role in the protection from CAC in the setting of chronic colitis, and suggest that the decreased SLC7A2 in inflammatory bowel disease (IBD) may contribute to CAC risk. Strategies to enhance L-Arg availability by supplementing L-Arg and/or increasing L-Arg uptake could represent a therapeutic approach in IBD to reduce the substantial long-term risk of colorectal carcinoma. 2018-09-10 2019-02 /pmc/articles/PMC6377304/ /pubmed/30202097 http://dx.doi.org/10.1038/s41388-018-0492-9 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Coburn, Lori A. Singh, Kshipra Asim, Mohammad Barry, Daniel P. Allaman, Margaret M. Al-Greene, Nicole T. Hardbower, Dana M. Polosukhina, Dina Williams, Christopher S. Delgado, Alberto G. Piazuelo, M. Blanca Washington, M. Kay Gobert, Alain P. Wilson, Keith T. Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title | Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title_full | Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title_fullStr | Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title_full_unstemmed | Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title_short | Loss of Solute Carrier Family 7 Member 2 Exacerbates Inflammation-Associated Colon Tumorigenesis |
title_sort | loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377304/ https://www.ncbi.nlm.nih.gov/pubmed/30202097 http://dx.doi.org/10.1038/s41388-018-0492-9 |
work_keys_str_mv | AT coburnloria lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT singhkshipra lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT asimmohammad lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT barrydanielp lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT allamanmargaretm lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT algreenenicolet lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT hardbowerdanam lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT polosukhinadina lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT williamschristophers lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT delgadoalbertog lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT piazuelomblanca lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT washingtonmkay lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT gobertalainp lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis AT wilsonkeitht lossofsolutecarrierfamily7member2exacerbatesinflammationassociatedcolontumorigenesis |